IH
Ivan Hyep sold $350K of BCAX stock
Ivan Hyep, Chief Financial Officer of Bicara Therapeutics Inc. (BCAX), sold 12,500 shares of BCAX stock worth $350K, per an SEC Form 4 filed Aug 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 10, 2026, 2 days before it was made public.
BCAX has moved -67.1% since the trade date, from $27.73 to $9.12 (Nov 19, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 2 days
- Price since
- -67.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4